- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Biosound signs deal with Summit
Ultrasound developer Biosound Esaote reported last month that it has brokered a partnership with Summit Medical Technologies of Arlington Heights, IL. The deal gives Summit exclusive U.S. marketing rights to Indianapolis-based Biosound's Advanced
Ultrasound developer Biosound Esaote reported last month that it has brokered a partnership with Summit Medical Technologies of Arlington Heights, IL. The deal gives Summit exclusive U.S. marketing rights to Indianapolis-based Biosound's Advanced Ultrasonography (AU) line of scanners. Summit will sell the units to radiologists, medical imaging centers, and breast imaging centers, while Biosound's sales force will continue to sell the system to remaining markets, including cardiology, vascular and general surgery, and neurology.
The most recent system in the AU family is AU5, introduced last year and cleared by the Food and Drug Administration this September (SCAN 9/17/97). Biosound hopes the deal with Summit Medical will give it increased access to the multispecialty radiology market and the women's health market.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
